Fasting glucose cutoff point: Where does the risk terminate? Tehran lipid and glucose study

Acta Diabetologica

Volumn 49, Issue 5, 2012, Pages 341-348

  Bozorgmanesh, Mohammadreza ^a   Hadaegh, Farzad ^a   Saadat, Navid ^b   Azizi, Fereidoun ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cutoff point; Diabetes; Fasting glucose; Prediction; Risk

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD GLUCOSE MONITORING; CALIBRATION; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; IRAN; MALE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; STATISTICAL ANALYSIS; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGE OF ONSET; BLOOD GLUCOSE; DIABETES MELLITUS; FASTING; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84867985509     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-011-0298-5     Document Type: Article

References (34)

1. Unwin N, Gan D, Whiting D (2010) The IDF diabetes atlas: providing evidence, raising awareness and promoting action. Diabetes Res Clin Pract 87:2-3
2. Harati H, Hadaegh F, Momenan AA, Ghanei L, Bozorgmanesh MR, Ghanbarian A, Mirmiran P, Azizi F (2010) Reduction in incidence of type 2 diabetes by lifestyle intervention in a middle eastern community. Am J Prev Med 38(6):628-636, e621. doi: 10.1016/j.amepre.2010.03.003
3. Goyder EC, McNally PG, Drucquer M, Spiers N, Botha JL (1998) Shifting of care for diabetes from secondary to primary care, 1990-5: review of general practices. BMJ 316(7143):1505-1506
4. Herman WH (2009) Predicting Risk for diabetes: choosing (or building) the right model. Ann Intern Med 150(11):812-814. doi: 10.1059/0003-4819-150-11- 200906020-00010
5. Schaefer C, Biermann T, Schroeder M, Fuhrhop I, Niemeier A, Rüther W, Algenstaedt P, Hansen-Algenstaedt N (2010) Early microvascular complications of prediabetes in mice with impaired glucose tolerance and dyslipidemia. Acta Diabetol 47(Suppl 1):19-27
6. Atkins RC, Zimmet P (2010) Diabetic kidney disease: act now or pay later. Nephrology 15(1):20-22
7. Tarquini R, Lazzeri C, Pala L, Rotella CM, Gensini GF (2010) The diabetic cardiomyopathy. Acta Diabetol. doi: 10.1007/s00592-010-0180-x
8. Greco D, Gambina F, Maggio F (2009) Ophthalmoplegia in diabetes mellitus: a retrospective study. Acta Diabetol 46(1):23-26
9. Nichols GA, Hillier TA, Brown JB (2007) Progression from newly acquired impaired fasting glusose to type 2 diabetes. Diabetes Care 30(2):228-233. doi: 10.2337/dc06-1392
10. Bozorgmanesh M, Hadaegh F, Ghaffari S, Harati H, Azizi F (2010) A simple risk score effectively predicted type 2 diabetes in Iranian adult population: population-based cohort study. Eur J Public Health. doi: 10.1093/eurpub/ckq074
11. Kahn HS, Cheng YJ, Thompson TJ, Imperatore G, Gregg EW (2009) Two risk-scoring systems for predicting incident diabetes mellitus in US adults age 45 to 64 Years. Ann Intern Med 150(11):741-751
12. Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Golden SH, Folsom AR, Chambless LE (2005) Identifying individuals at high risk for diabetes: the atherosclerosis risk in communities study. Diabetes Care 28(8):2013-2018
13. Schriger DL, Lorber B (2004) Lowering the cut point for impaired fasting glucose. Diabetes Care 27(2):592-595. doi: 10.2337/diacare.27.2.592
14. Garber A, Handelsman Y, Einhorn D, Bergman D, Bloomgarden Z, Fonseca V, Timothy Garvey W, Gavin III J, Grunberger G, Horton E (2008) Diagnosis and management of prediabetes in the continuum of hyperglycemiawhen do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocrine Practice 14(7):933-946
15. Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, Mehrabi Y, Zahedi-Asl S (2009) Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study phase II. Trials 10(1):5. doi: 10.1186/1745-6215-10-5
16. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26(11):3160-3167. doi: 10.2337/diacare.26.11.3160
17. Harrell FE (2001) Regression modeling strategies. Springer, New York
18. Akaike H (1974) A new look at the statistical model identification. IEEE Trans Automat Contr AC-19:716-723
19. D'Agostino RB, Nam BH (2004) Evaluation of the performance of survival analysis models: Discrimination and Calibration measures. In: Balakrishnan N, Rao CR (eds) Handbook of Statistics, Survival Methods, vol 23. Elsevier B.V., Amsterdam, pp 1-25. doi: 10.16/S0169-7161(03)23001-7
20. Royston P (2006) Explained variation for survival models. Stata J 6(1):83-96
21. Spiegelhalter DJ (1986) Probabilistic prediction in patient management and clinical trials. Stat Med 5(5):421-433
22. Ferrannini E, Nannipieri M, Williams K, Gonzales C, Haffner SM, Stern MP (2004) Mode of onset of type 2 diabetes from normal or impaired glucose tolerance. Diabetes 53(1):160-165. doi: 10.2337/diabetes.53.1.160
23. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344(18):1343-1350
24. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care 20(4):537-544. doi: 10.2337/diacare.20.4.537
25. Diabetes Prevention Program Research Group (2002) Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346(6):393-403. doi: 10.1056/NEJMoa012512
26. Forouhi NG, Balkau B, Borch-Johnsen K, Dekker J, Glumer C, Qiao Q, Spijkerman A, Stolk R, Tabac A, Wareham NJ (2006) The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group. Diabetologia 49(5):822-827. doi: 10.1007/s00125-006-0189-4
27. Schulze MB, Fritsche A, Boeing H, Joost HG (2010) Fasting plasma glucose and type 2 diabetes risk: a non-linear relationship. Diabet Med 27(4):473-476. doi: 10.1111/j.1464-5491.2009.02919.x
28. Sundquist J, Johansson S-E, Sundquist K (2010) Levelling off of prevalence of obesity in the adult population of Sweden between 2000/01 and 2004/05. BMC Public Health 10(1):119
29. Ogden C, Carroll M, Curtin L, McDowell M, Tabak C, Flegal K (2006) Prevalence of overweight and obesity in the United States, 1999-2004. Jama 295(13):1549
30. Shaw JE, Zimmet PZ, Hodge AM, de Courten M, Dowse GK, Chitson P, Tuomilehto J, Alberti KG (2000) Impaired fasting glucose: how low should it go? Diabetes Care 23(1):34-39. doi: 10.2337/diacare.23.1.34
31. Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, Knowler WC (2000) The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 23(8):1108-1112. doi: 10.2337/diacare.23.8.1108
32. Cryer P (1997) Hypoglycemia: pathophysiology, diagnosis, and treatment. Oxford University Press, USA
33. Bozorgmanesh M, Hadaegh F, Zabetian A, Azizi F (2010) San Antonio heart study diabetes prediction model applicable to a Middle Eastern population? Tehran glucose and lipid study. Int J Public Health 55(4):315-323. doi: 10.1007/s00038-010-0130-y
34. Pishdad GR (2005) Low incidence of type 1 diabetes in Iran. Diabetes Care 28(4):927-928